7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay

Shunji Kato, Stefano Petruzzelli, Elise D. Bowman, Ken W Turteltaub, Brunhilde Blomeke, Ainsley Weston, Peter G. Shields

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

7-Alkyldeoxyguanosine DNA adducts may be a marker for some N-nitroso compound exposures and subsequent human cancer risk. A sensitive and highly specific assay for the detection of 7-methyl-2′-deoxyguanosine-3′-monophosphate (7-methyldGp) and 7-ethyl-2′-deoxyguanosine-3′-monophosphate (7-ethyldGp) has been developed by combining two different HPLC purification steps with the 32P-postlabeling assay. We previously reported that ion-pair reverse-phase (IP) chromatography coupled with the 32P-postlabeling assay detects 7-methyldGp in human lung, but have found that other nucleotides and unknown adducts co-elute. Thus, weak anion exchange (AE) HPLC was added in tandem with IP HPLC prior to the 32P-postlabeling assay. 2′-Deoxyguanosine-3′-monophosphate (dGp) is incorporated into the assay as an internal standard for the assessment of enzyme labeling efficiency and adduct recovery. The methodology was validated using radiolabeled DNA and liquid scintillation counting, which accounts for adduct loss from enzymatic digestion to detection. Levels of 7-ethyldGp also were correlated with accelerator mass spectrometry. The overall adduct recovery with this method was 58% for 7-methyldGp and 98% for 7-ethyldGp. The detection limit for both assays using 100 μg of DNA was one adduct in 108 unmodified dGp. 7-MethyldGp and 7-ethyldGp levels were determined in ten human lung samples at levels of 1.4-5.4 and 0.6-3.1 adducts per 107 dGp respectively, and in five human lymphocyte samples at levels of 5.0-8.3 and 0.3-1.4 adducts per 107 dGp respectively. Combining the two HPLC purification steps and the 32P-postlabeling assay attains chemical specificity, retains sufficient quantitative sensitivity and should be useful in human biomonitoring studies.

Original languageEnglish (US)
Pages (from-to)545-550
Number of pages6
JournalCarcinogenesis
Volume14
Issue number4
StatePublished - Apr 1993
Externally publishedYes

Fingerprint

High-performance Liquid Chromatography
Assays
High Pressure Liquid Chromatography
Lung
Purification
Reverse
Recovery
Ions
Nitroso Compounds
Scintillation Counting
Detection Limit
Scintillation
DNA Adducts
Lymphocytes
Environmental Monitoring
DNA
Mass Spectrometry
Reverse-Phase Chromatography
Accelerator
Chromatography

ASJC Scopus subject areas

  • Cancer Research
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Behavioral Neuroscience

Cite this

Kato, S., Petruzzelli, S., Bowman, E. D., Turteltaub, K. W., Blomeke, B., Weston, A., & Shields, P. G. (1993). 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. Carcinogenesis, 14(4), 545-550.

7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. / Kato, Shunji; Petruzzelli, Stefano; Bowman, Elise D.; Turteltaub, Ken W; Blomeke, Brunhilde; Weston, Ainsley; Shields, Peter G.

In: Carcinogenesis, Vol. 14, No. 4, 04.1993, p. 545-550.

Research output: Contribution to journalArticle

Kato, S, Petruzzelli, S, Bowman, ED, Turteltaub, KW, Blomeke, B, Weston, A & Shields, PG 1993, '7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay', Carcinogenesis, vol. 14, no. 4, pp. 545-550.
Kato S, Petruzzelli S, Bowman ED, Turteltaub KW, Blomeke B, Weston A et al. 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. Carcinogenesis. 1993 Apr;14(4):545-550.
Kato, Shunji ; Petruzzelli, Stefano ; Bowman, Elise D. ; Turteltaub, Ken W ; Blomeke, Brunhilde ; Weston, Ainsley ; Shields, Peter G. / 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. In: Carcinogenesis. 1993 ; Vol. 14, No. 4. pp. 545-550.
@article{452041c745474722a76c052f2355a743,
title = "7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay",
abstract = "7-Alkyldeoxyguanosine DNA adducts may be a marker for some N-nitroso compound exposures and subsequent human cancer risk. A sensitive and highly specific assay for the detection of 7-methyl-2′-deoxyguanosine-3′-monophosphate (7-methyldGp) and 7-ethyl-2′-deoxyguanosine-3′-monophosphate (7-ethyldGp) has been developed by combining two different HPLC purification steps with the 32P-postlabeling assay. We previously reported that ion-pair reverse-phase (IP) chromatography coupled with the 32P-postlabeling assay detects 7-methyldGp in human lung, but have found that other nucleotides and unknown adducts co-elute. Thus, weak anion exchange (AE) HPLC was added in tandem with IP HPLC prior to the 32P-postlabeling assay. 2′-Deoxyguanosine-3′-monophosphate (dGp) is incorporated into the assay as an internal standard for the assessment of enzyme labeling efficiency and adduct recovery. The methodology was validated using radiolabeled DNA and liquid scintillation counting, which accounts for adduct loss from enzymatic digestion to detection. Levels of 7-ethyldGp also were correlated with accelerator mass spectrometry. The overall adduct recovery with this method was 58{\%} for 7-methyldGp and 98{\%} for 7-ethyldGp. The detection limit for both assays using 100 μg of DNA was one adduct in 108 unmodified dGp. 7-MethyldGp and 7-ethyldGp levels were determined in ten human lung samples at levels of 1.4-5.4 and 0.6-3.1 adducts per 107 dGp respectively, and in five human lymphocyte samples at levels of 5.0-8.3 and 0.3-1.4 adducts per 107 dGp respectively. Combining the two HPLC purification steps and the 32P-postlabeling assay attains chemical specificity, retains sufficient quantitative sensitivity and should be useful in human biomonitoring studies.",
author = "Shunji Kato and Stefano Petruzzelli and Bowman, {Elise D.} and Turteltaub, {Ken W} and Brunhilde Blomeke and Ainsley Weston and Shields, {Peter G.}",
year = "1993",
month = "4",
language = "English (US)",
volume = "14",
pages = "545--550",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay

AU - Kato, Shunji

AU - Petruzzelli, Stefano

AU - Bowman, Elise D.

AU - Turteltaub, Ken W

AU - Blomeke, Brunhilde

AU - Weston, Ainsley

AU - Shields, Peter G.

PY - 1993/4

Y1 - 1993/4

N2 - 7-Alkyldeoxyguanosine DNA adducts may be a marker for some N-nitroso compound exposures and subsequent human cancer risk. A sensitive and highly specific assay for the detection of 7-methyl-2′-deoxyguanosine-3′-monophosphate (7-methyldGp) and 7-ethyl-2′-deoxyguanosine-3′-monophosphate (7-ethyldGp) has been developed by combining two different HPLC purification steps with the 32P-postlabeling assay. We previously reported that ion-pair reverse-phase (IP) chromatography coupled with the 32P-postlabeling assay detects 7-methyldGp in human lung, but have found that other nucleotides and unknown adducts co-elute. Thus, weak anion exchange (AE) HPLC was added in tandem with IP HPLC prior to the 32P-postlabeling assay. 2′-Deoxyguanosine-3′-monophosphate (dGp) is incorporated into the assay as an internal standard for the assessment of enzyme labeling efficiency and adduct recovery. The methodology was validated using radiolabeled DNA and liquid scintillation counting, which accounts for adduct loss from enzymatic digestion to detection. Levels of 7-ethyldGp also were correlated with accelerator mass spectrometry. The overall adduct recovery with this method was 58% for 7-methyldGp and 98% for 7-ethyldGp. The detection limit for both assays using 100 μg of DNA was one adduct in 108 unmodified dGp. 7-MethyldGp and 7-ethyldGp levels were determined in ten human lung samples at levels of 1.4-5.4 and 0.6-3.1 adducts per 107 dGp respectively, and in five human lymphocyte samples at levels of 5.0-8.3 and 0.3-1.4 adducts per 107 dGp respectively. Combining the two HPLC purification steps and the 32P-postlabeling assay attains chemical specificity, retains sufficient quantitative sensitivity and should be useful in human biomonitoring studies.

AB - 7-Alkyldeoxyguanosine DNA adducts may be a marker for some N-nitroso compound exposures and subsequent human cancer risk. A sensitive and highly specific assay for the detection of 7-methyl-2′-deoxyguanosine-3′-monophosphate (7-methyldGp) and 7-ethyl-2′-deoxyguanosine-3′-monophosphate (7-ethyldGp) has been developed by combining two different HPLC purification steps with the 32P-postlabeling assay. We previously reported that ion-pair reverse-phase (IP) chromatography coupled with the 32P-postlabeling assay detects 7-methyldGp in human lung, but have found that other nucleotides and unknown adducts co-elute. Thus, weak anion exchange (AE) HPLC was added in tandem with IP HPLC prior to the 32P-postlabeling assay. 2′-Deoxyguanosine-3′-monophosphate (dGp) is incorporated into the assay as an internal standard for the assessment of enzyme labeling efficiency and adduct recovery. The methodology was validated using radiolabeled DNA and liquid scintillation counting, which accounts for adduct loss from enzymatic digestion to detection. Levels of 7-ethyldGp also were correlated with accelerator mass spectrometry. The overall adduct recovery with this method was 58% for 7-methyldGp and 98% for 7-ethyldGp. The detection limit for both assays using 100 μg of DNA was one adduct in 108 unmodified dGp. 7-MethyldGp and 7-ethyldGp levels were determined in ten human lung samples at levels of 1.4-5.4 and 0.6-3.1 adducts per 107 dGp respectively, and in five human lymphocyte samples at levels of 5.0-8.3 and 0.3-1.4 adducts per 107 dGp respectively. Combining the two HPLC purification steps and the 32P-postlabeling assay attains chemical specificity, retains sufficient quantitative sensitivity and should be useful in human biomonitoring studies.

UR - http://www.scopus.com/inward/record.url?scp=0027318416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027318416&partnerID=8YFLogxK

M3 - Article

C2 - 8386066

AN - SCOPUS:0027318416

VL - 14

SP - 545

EP - 550

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 4

ER -